157 related articles for article (PubMed ID: 15080875)
21. Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.
Goudah A
Vet Res Commun; 2003 Oct; 27(7):555-66. PubMed ID: 14609267
[TBL] [Abstract][Full Text] [Related]
22. Modified plasma and abomasal disposition of albendazole in nematode-infected sheep.
Alvarez LI; Sánchez SF; Lanusse CE
Vet Parasitol; 1997 May; 69(3-4):241-53. PubMed ID: 9195734
[TBL] [Abstract][Full Text] [Related]
23. The pharmacokinetics of albendazole metabolites following administration of albendazole, albendazole sulfoxide and netobimin to one-month- and eight-month-old sheep.
McKellar QA; Coop RL; Jackson F
Int J Parasitol; 1995 Oct; 25(10):1207-12. PubMed ID: 8557468
[TBL] [Abstract][Full Text] [Related]
24. Ex vivo diffusion of albendazole and its sulfoxide metabolite into ascaris suum and Fasciola hepatica.
Alvarez LI; Mottier ML; Sánchez SF; Lanusse CE
Parasitol Res; 2001 Nov; 87(11):929-34. PubMed ID: 11728018
[TBL] [Abstract][Full Text] [Related]
25. Dose-dependent systemic exposure of albendazole metabolites in lambs.
Alvarez L; Suárez G; Ceballos L; Moreno L; Lanusse C
J Vet Pharmacol Ther; 2012 Aug; 35(4):365-72. PubMed ID: 21819410
[TBL] [Abstract][Full Text] [Related]
26. Fasting-induced changes to the pharmacokinetic behaviour of albendazole and its metabolites in calves.
Sánchez SF; Alvarez LI; Lanusse CE
J Vet Pharmacol Ther; 1997 Feb; 20(1):38-47. PubMed ID: 9049948
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep.
Capece BP; Castells G; Pérez F; Arboix M; Cristòfol C
Vet Res Commun; 2000 Jul; 24(5):339-48. PubMed ID: 10868551
[TBL] [Abstract][Full Text] [Related]
28. Disposition kinetics of albendazole and metabolites in laying hens.
Bistoletti M; Alvarez L; Lanusse C; Moreno L
J Vet Pharmacol Ther; 2013 Apr; 36(2):161-8. PubMed ID: 22533477
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs.
Alvarez L; Lifschitz A; Entrocasso C; Manazza J; Mottier L; Borda B; Virkel G; Lanusse C
J Vet Pharmacol Ther; 2008 Jun; 31(3):230-9. PubMed ID: 18471144
[TBL] [Abstract][Full Text] [Related]
30. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
Gokbulut C; Akar F; McKellar QA
Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142
[TBL] [Abstract][Full Text] [Related]
31. Comparative drug systemic exposure and clinical efficacy against resistant nematodes in lambs treated with different albendazole formulations.
Suárez G; Alvarez L; Castells D; Correa O; Fagiolino P; Lanusse C
J Vet Pharmacol Ther; 2011 Dec; 34(6):557-64. PubMed ID: 21371047
[TBL] [Abstract][Full Text] [Related]
32. Hepatic biotransformation pathways and ruminal metabolic stability of the novel anthelmintic monepantel in sheep and cattle.
Ballent M; Virkel G; Maté L; Viviani P; Lanusse C; Lifschitz A
J Vet Pharmacol Ther; 2016 Oct; 39(5):488-96. PubMed ID: 26923886
[TBL] [Abstract][Full Text] [Related]
33. Bioavailability of albendazole sulphoxide after netobimin administration in sheep: effects of fenbendazole coadministration.
Merino G; Alvarez AI; Redondo PA; Garcia JL; Larrodé OM; Prieto JG
Res Vet Sci; 1999 Jun; 66(3):281-3. PubMed ID: 10333473
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and tissue residues of hydrochloric acid albendazole sulfoxide and its metabolites in crucian carp (Carassius auratus) after oral administration.
Li Z; Chen C; Ai D; Wang C; Li J; Qi Y; Yi W; Shen H; Cao J
Environ Toxicol Pharmacol; 2012 Mar; 33(2):197-204. PubMed ID: 22227164
[TBL] [Abstract][Full Text] [Related]
35. Enhanced plasma and target tissue availabilities of albendazole and albendazole sulphoxide in fasted calves: evaluation of different fasting intervals.
Sánchez S; Alvarez L; Sallovitz J; Lanusse C
J Vet Pharmacol Ther; 2000 Aug; 23(4):193-201. PubMed ID: 11126322
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of pharmacological interactions after administration of a levamisole, albendazole and ivermectin triple combination in lambs.
Suarez G; Alvarez L; Castells D; Moreno L; Fagiolino P; Lanusse C
Vet Parasitol; 2014 Mar; 201(1-2):110-9. PubMed ID: 24462508
[TBL] [Abstract][Full Text] [Related]
37. Comparative plasma disposition kinetics of albendazole, fenbendazole, oxfendazole and their metabolites in adult sheep.
Lanusse CE; Gascon LH; Prichard RK
J Vet Pharmacol Ther; 1995 Jun; 18(3):196-203. PubMed ID: 7674455
[TBL] [Abstract][Full Text] [Related]
38. Albendazole sulphoxide enantiomeric ratios in plasma and target tissues after intravenous administration of ricobendazole to cattle.
Cristofol C; Virkel G; Alvarez L; Sánchez S; Arboix M; Lanusse C
J Vet Pharmacol Ther; 2001 Apr; 24(2):117-24. PubMed ID: 11442786
[TBL] [Abstract][Full Text] [Related]
39. Albendazole sulphoxide kinetic disposition after treatment with different formulations in dogs.
Dib A; Palma S; Suárez G; Farías C; Cabrera P; Castro S; Allemandi D; Moreno L; Lanusse C; Sánchez Bruni S
J Vet Pharmacol Ther; 2011 Apr; 34(2):136-41. PubMed ID: 21395604
[TBL] [Abstract][Full Text] [Related]
40. Phase I biotransformation of albendazole in lancet fluke (Dicrocoelium dendriticum).
Cvilink V; Szotáková B; Krízová V; Lamka J; Skálová L
Res Vet Sci; 2009 Feb; 86(1):49-55. PubMed ID: 18565554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
